Literature DB >> 8761511

Spontaneous aortic rupture in a 22-year-old.

M A Memon1, C M Nicholson, J Clayton-Smith.   

Abstract

Entities:  

Mesh:

Year:  1996        PMID: 8761511      PMCID: PMC2398452          DOI: 10.1136/pgmj.72.847.311

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  7 in total

1.  Linkage of a polymorphic marker for the type III collagen gene (COL3A1) to atypical autosomal dominant Ehlers-Danlos syndrome type IV in a large Belgian pedigree.

Authors:  A C Nicholls; A De Paepe; P Narcisi; R Dalgleish; F De Keyser; M Matton; F M Pope
Journal:  Hum Genet       Date:  1988-03       Impact factor: 4.132

2.  Ehlers-Danlos syndrome type IV: dramatic, deceptive, and deadly.

Authors:  R S Sparkman
Journal:  Am J Surg       Date:  1984-05       Impact factor: 2.565

3.  Pregnancy complications in type IV Ehlers-Danlos Syndrome.

Authors:  N L Rudd; C Nimrod; K A Holbrook; P H Byers
Journal:  Lancet       Date:  1983-01-01       Impact factor: 79.321

4.  Vascular complications in the Ehlers-Danlos syndrome.

Authors:  M Krog; B Almgren; I Eriksson; S Nordström
Journal:  Acta Chir Scand       Date:  1983

5.  Two vascular complications of the Ehlers-Danlos syndrome.

Authors:  S Brearley; J Fowler; J D Hamer
Journal:  Eur J Vasc Surg       Date:  1993-03

6.  Clinical presentations of Ehlers Danlos syndrome type IV.

Authors:  F M Pope; P Narcisi; A C Nicholls; M Liberman; J W Oorthuys
Journal:  Arch Dis Child       Date:  1988-09       Impact factor: 3.791

7.  Spontaneous arterial perforation: the Ehlers-Danlos specter.

Authors:  D F Cikrit; J H Miles; D Silver
Journal:  J Vasc Surg       Date:  1987-02       Impact factor: 4.268

  7 in total
  1 in total

Review 1.  Spontaneous common iliac arteries rupture in Ehlers-Danlos syndrome type IV: report of two cases and review of the literature.

Authors:  K Habib; M A Memon; D A Reid; B J Fairbrother
Journal:  Ann R Coll Surg Engl       Date:  2001-03       Impact factor: 1.891

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.